FIGS, Inc. (FIGS)
| Market Cap | 2.56B +121.6% |
| Revenue (ttm) | 710.08M +24.7% |
| Net Income | 61.92M +762.2% |
| EPS | 0.33 +653.9% |
| Shares Out | 166.14M |
| PE Ratio | 47.11 |
| Forward PE | 43.47 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,224,695 |
| Open | 15.21 |
| Previous Close | 15.10 |
| Day's Range | 15.13 - 15.61 |
| 52-Week Range | 6.50 - 17.48 |
| Beta | 1.02 |
| Analysts | Buy |
| Price Target | 18.63 (+20.82%) |
| Earnings Date | Aug 6, 2026 |
About FIGS
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports apparel, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, bags, baseball caps... [Read more]
Financial Performance
In 2025, FIGS, Inc.'s revenue was $631.10 million, an increase of 13.60% compared to the previous year's $555.56 million. Earnings were $34.25 million, an increase of 1159.19%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for FIGS stock is "Buy." The 12-month stock price target is $18.63, which is an increase of 20.82% from the latest price.
News
Figs price target raised to $16 from $14 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Figs (FIGS) to $16 from $14 and keeps a Neutral rating on the shares.
Figs price target lowered to $16 from $17 at Telsey Advisory
Telsey Advisory analyst Dana Telsey lowered the firm’s price target on Figs (FIGS) to $16 from $17 and keeps a Market Perform rating on the shares. The company reported Q2…
Figs price target raised to $18 from $17 at Roth Capital
Roth Capital raised the firm’s price target on Figs (FIGS) to $18 from $17 and keeps a Buy rating on the shares. Figs exceeded expectations with another strong quarter of…
Figs price target raised to $22 from $20 at BTIG
BTIG raised the firm’s price target on Figs (FIGS) to $22 from $20 and keeps a Buy rating on the shares. Figs delivered another strong quarter with 29% sales growth,…
Figs price target raised to $20 from $19 at KeyBanc
KeyBanc analyst Noah Zatzkin raised the firm’s price target on Figs (FIGS) to $20 from $19 and keeps an Overweight rating on the shares. The firm notes the company posted…
Figs price target raised to $20 from $17 at Barclays
Barclays analyst Adrienne Yih raised the firm’s price target on Figs (FIGS) to $20 from $17 and keeps an Overweight rating on the shares.
FIGS, Inc. Earnings Call Transcript: Q2 2026
Net revenues rose 29% year-over-year to $196.6 million, with strong growth across all segments and geographies. Adjusted EBITDA margin reached 18.6%, and full-year revenue growth guidance was raised to 20%. International and non-scrub wear segments delivered standout performance.
FIGS, Inc. Slides: Q2 2026
FIGS, Inc. has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
FIGS, Inc. Earnings release: Q2 2026
FIGS, Inc. released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
FIGS, Inc. Quarterly report: Q2 2026
FIGS, Inc. has published its Q2 2026 quarterly earnings report on August 6, 2026.
Figs reports Q2 EPS 15c, consensus 7c
Reports Q2 revenue $196.6M, consensus $186.11M. “FIGS (FIGS)’ exceptional Q2 performance was powered by strong, ongoing traction across the business, with outperformance on both the top and bottom lin...
FIGS Releases Second Quarter 2026 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released...
FIGS Announces Date of Second Quarter 2026 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will releas...
FIGS, Inc. Transcript: Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference
Sales growth has re-accelerated across all categories and regions, driven by product innovation and marketing. Profitability is improving despite tariff headwinds, with ongoing investments in B2B, retail expansion, and product layering. Strong cash flow supports both growth and shareholder returns.
FIGS, Inc. Transcript: AGM 2026
The meeting, held virtually, covered director elections, auditor ratification, and executive compensation approval. All proposals passed, with final results to be filed on Form 8-K. No shareholder questions were received.
FIGS Announces Participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spe...
FIGS, Inc. Earnings Call Transcript: Q1 2026
Net revenues rose 28% year-over-year to $159.9 million, with active customers surpassing three million and strong growth across all segments. Full-year guidance was raised, reflecting confidence in continued momentum despite tariff and freight headwinds.
FIGS, Inc. Slides: Q1 2026
FIGS, Inc. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
FIGS, Inc. Earnings release: Q1 2026
FIGS, Inc. released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
FIGS, Inc. Quarterly report: Q1 2026
FIGS, Inc. has published its Q1 2026 quarterly earnings report on May 7, 2026.
FIGS Releases First Quarter 2026 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released...
FIGS and Noah Wyle Launch Long-Term Partnership to Advocate for the Healthcare Workforce and Reduce Medical Debt
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, today announced a long-term partnership with Noah Wyle, Emmy-award winning executive produc...
Figs price target raised to $19 from $17 at KeyBanc
KeyBanc raised the firm’s price target on Figs (FIGS) to $19 from $17 to reflect recent share momentum post-Q4 earnings and on maintained conviction that improving fundamentals are more structural…